Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
Obesity pathophysiology and metabolic science: Understanding the hormonal, neurological, and genetic factors that drive weight gain and resist weight loss GLP-1 receptor agonist mastery: Comprehensive training on semaglutide, tirzepatide, and emerging agents, including prescribing protocols, titration schedules, contraindication screening, and side effect management Comprehensive pharmacotherapy: Phentermine, phentermine-topiramate, naltrexone-bupropion, orlistat, metformin, and combination strategies Peptide therapy and compounded medications: Navigating the regulatory and clinical landscape for compounded semaglutide and adjunctive peptides Metabolic testing and body composition analysis: Hands-on training with indirect calorimetry, DEXA scanning, and bioimpedance analysis Nutritional programming: Developing individualized meal plans, protein optimization for lean mass preservation, and supplement protocols Behavioral health integration: Practical CBT and motivational interviewing techniques for the clinical weight management setting Business and practice operations: Program pricing, patient acquisition, billing and coding, staff training, and scaling strategies Why AAOPM The AAOPM approach to medical weight loss certification is distinguished by its emphasis on immediate clinical applicability
Patients who use this period well building muscle, establishing sustainable nutrition patterns, addressing sleep and stress are far more likely to maintain their results
View our Privacy Policy Copyright 2026 Bettormetrics To learn more about Bettormetrics and how it can improve your trading performance, email [email protected] Bettormetrics is a trading name of Open Metrics Limited, registered in England and Wales under company number 13785217 and with its registered office at: 2 Toomers Wharf, Canal Walk, Newbury, Berkshire, RG14 1DY
